Zidovudine
Who holds supplier records for Zidovudine? 7 organisations hold a current record for Zidovudine: an active US FDA Type II Drug Master File or a CEP. A further 11 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5) and China (2).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Zidovudine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/zidovudine
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
5 of the 7 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Zidovudine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 17638, 18714 · latest filing Aug 2005
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 18291, 24608 · latest filing Feb 2011
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 17751 · latest filing Oct 2004
- Shanghai Desano Chemical Pharmaceutical Co., LtdChinaCEPActive DMF 21277 · latest filing Jan 2008
- Cipla LimitedIndia Company GMP cert on recordActive DMF 16677 · latest filing Jun 2003
- SHANGHAI SHYNDEC PHARMACEUTICAL HAIMEN CO LTDChinaActive DMF 27207 · latest filing Jun 2013
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia Company GMP cert on recordActive DMF 25009 · latest filing Jun 2011
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Zidovudine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2007-318 - Rev 07 Zidovudine | Sept 2025 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2008-333 - Rev 07 Zidovudine | May 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2005-063 - Rev 05 Zidovudine | Nov 2023 | — |
| SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. Laogang Town | CN | R0-CEP 2021-015 - Rev 00 Zidovudine | Jul 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (11)
Organisations whose Type II DMFs for Zidovudine are no longer active. These show a past filing, not current supply.
Show all 11 historical records
- Zhejiang Langhua Pharmaceutical Co. Ltd.China · Inactive DMF 26695 · filed Oct 2012
- MATRIX PHARMA GROUP XIAMEN LTDInactive DMF 25082 · filed Jun 2011
- MYLAN LABORATORIES LTDInactive DMF 24450, 24550 · filed Dec 2010
- India · Inactive DMF 21570 · filed Apr 2008
- SIBRA PHARMACEUTICALS LTD AN ARCH ENTERPRISEInactive DMF 21325 · filed Feb 2008
- RANBAXY LABORATORIES LTDInactive DMF 20703 · filed Jul 2007
- MATRIX LABORATORIES LTDInactive DMF 17952 · filed Dec 2004
- South Korea · Inactive DMF 13181 · filed Sept 1998
- ESTEVE QUIMICA SAInactive DMF 10866 · filed Apr 1994
- HOUBA INCInactive DMF 9712 · filed Jun 1992
- SIGNA SA DE CVInactive DMF 8818 · filed Nov 1990
Overview
Zidovudine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL129).
Chemical identity
- IUPAC name
- 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
- Canonical SMILES
- CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]
- InChIKey
- HBOMLICNUCNMMY-XLPZGREQSA-N
- Synonyms
- 3'-azt, Azidothymidine, AZT, BW A509U, BW-A-509U, BW-A509U, Bwa509u, COMPOUND S, COMPOUND-S, NSC-602670, Retrovir, Zidovudina
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- Mechanism of action
- Nucleoside Reverse Transcriptase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Zidovudine?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Zidovudine: APITORIA PHARMA PRIVATE LTD (India), Hetero Labs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), Shanghai Desano Chemical Pharmaceutical Co., Ltd (China), Cipla Limited (India), SHANGHAI SHYNDEC PHARMACEUTICAL HAIMEN CO LTD (China) and SOLARA ACTIVE PHARMA SCIENCES LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Zidovudine Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 17638, 18714), Hetero Labs Limited (DMF 18291, 24608), MATRIX PHARMACORP PRIVATE LTD (DMF 17751), Shanghai Desano Chemical Pharmaceutical Co., Ltd (DMF 21277), Cipla Limited (DMF 16677), SHANGHAI SHYNDEC PHARMACEUTICAL HAIMEN CO LTD (DMF 27207) and SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 25009). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Zidovudine records mean?
11 organisations have only inactive Type II DMFs for Zidovudine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Zidovudine have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Zidovudine on the EDQM register, including MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), HETERO LABS LIMITED Hyderabad (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. Laogang Town (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Zidovudine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Zidovudine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.